skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Synthesis and in-vivo detection of boronated compounds for use in BNCT

Technical Report ·
DOI:https://doi.org/10.2172/7151243· OSTI ID:7151243

The primary objective of the DOE Program at the University of Tennessee Biomedical Imaging Center is the development of new technology to detect boron compounds in-vivo. The research focuses on the development of multinuclear magnetic resonance imaging (MRI) and spectroscopy (MRS) techniques for verifying and measuring BNCT agents in-vivo. A small but significant portion of the effort is directed toward the design of boron-containing neutron-capture-therapy agents. The UT -- DOE program is unique in that it has access to two state-of-the-art multinuclear magnetic resonance imaging units housed in the Biomedical Imaging Center at the University of Tennessee Medical Center at Knoxville. Included in this report are two sections describing research accomplishments in multinuclear magnetic resonance imaging and synthesis of potential BNCT agents.

Research Organization:
Tennessee Univ. Hospital, Knoxville, TN (USA). Dept. of Radiology
Sponsoring Organization:
DOE/ER
DOE Contract Number:
FG05-89ER60892
OSTI ID:
7151243
Report Number(s):
DOE/ER/60892-1; ON: DE90008974; TRN: 90-010197
Country of Publication:
United States
Language:
English